What does this research mean for the field?

Specific baseline immune profiles, including low levels of CD4+ memory Tregs and CD4- central memory T cells, along with younger age and low peanut-specific IgE, predict complete desensitization in peanut-allergic children undergoing oral immunotherapy. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To identify baseline and on-treatment immunological profiles associated with successful desensitization outcomes in young children undergoing peanut oral immunotherapy.

August 27, 2026Allergy Asthma and Clinical ImmunologyOpen Access

Baseline immune profiles are associated with positive outcomes in young children with a peanut allergy, enrolled in a randomised clinical trial for oral immunotherapy

View Full Paper

Ask AI

Bookmark

Authors

ICIsabelle Coenen AFAbbey Figliomeni KPKimberley Parkin

Discussion

Member takes

Overview

Randomized trial finds baseline immune profiles correlate with desensitization success during peanut oral immunotherapy in young children, highlighting biomarkers to predict treatment response.

Key Points

To identify baseline and on-treatment immunological profiles associated with successful desensitization outcomes in young children undergoing peanut oral immunotherapy.
Assessed blood samples from 49 peanut-allergic children aged 1–4 years randomized to peanut oral immunotherapy (n=24) or strict peanut avoidance (n=25) for 12 months in the Early Peanut Immunotherapy in Children (EPIC) trial.
Evaluated desensitization via an end-of-treatment oral food challenge and profiled 30 immune cell subsets using flow cytometry and an FcεR1 expression panel at baseline, 12 weeks (intervention arm), and end of treatment.
Oral immunotherapy induced partial or complete desensitization in 91.3% of the intervention group compared to 20.8% in the avoidance group.
Intervention increased basophils, monocytes, and dendritic cells by 12 weeks, and expanded CD4- T effector memory cells and mast cell progenitors by end of treatment.
Complete desensitization was significantly associated with younger age, lower baseline peanut-specific IgE, reduced baseline CD4+ memory Tregs, and reduced CD4- central memory T cells, whereas higher baseline basophils were linked to partial desensitization.

Cite This Study

Coenen et al. (2026) studied this question.

synapsesocial.com/papers/6a90053410c91c1e92622677 https://doi.org/10.1186/s13223-026-01061-x

View Full Paper

Ask AI

Bookmark

August 27, 2026Allergy Asthma and Clinical ImmunologyOpen Access

Baseline immune profiles are associated with positive outcomes in young children with a peanut allergy, enrolled in a randomised clinical trial for oral immunotherapy

View Full Paper

Ask AI

Bookmark

Authors

ICIsabelle Coenen AFAbbey Figliomeni KPKimberley Parkin

Discussion

Member takes

Overview

Randomized trial finds baseline immune profiles correlate with desensitization success during peanut oral immunotherapy in young children, highlighting biomarkers to predict treatment response.

Key Points

To identify baseline and on-treatment immunological profiles associated with successful desensitization outcomes in young children undergoing peanut oral immunotherapy.
Assessed blood samples from 49 peanut-allergic children aged 1–4 years randomized to peanut oral immunotherapy (n=24) or strict peanut avoidance (n=25) for 12 months in the Early Peanut Immunotherapy in Children (EPIC) trial.
Evaluated desensitization via an end-of-treatment oral food challenge and profiled 30 immune cell subsets using flow cytometry and an FcεR1 expression panel at baseline, 12 weeks (intervention arm), and end of treatment.
Oral immunotherapy induced partial or complete desensitization in 91.3% of the intervention group compared to 20.8% in the avoidance group.
Intervention increased basophils, monocytes, and dendritic cells by 12 weeks, and expanded CD4- T effector memory cells and mast cell progenitors by end of treatment.
Complete desensitization was significantly associated with younger age, lower baseline peanut-specific IgE, reduced baseline CD4+ memory Tregs, and reduced CD4- central memory T cells, whereas higher baseline basophils were linked to partial desensitization.

Cite This Study

Coenen et al. (2026) studied this question.

synapsesocial.com/papers/6a90053410c91c1e92622677 https://doi.org/10.1186/s13223-026-01061-x

View Full Paper

Ask AI

Bookmark